Literature DB >> 21152160

Non-stimulant treatment for attention deficit hyperactivity disorder.

Kumar Budur1, Maju Mathews, Babatunde Adetunji, Manu Mathews, Jamal Mahmud.   

Abstract

Entities:  

Year:  2005        PMID： 21152160      PMCID： PMC3000197     

Source DB:  PubMed          Journal:  Psychiatry (Edgmont)        ISSN： 1550-5952


× No keyword cloud information.
  22 in total

1.  A naturalistic assessment of protriptyline for attention-deficit hyperactivity disorder.

Authors:  T E Wilens; J Biederman; A M Abrantes; T J Spencer
Journal:  J Am Acad Child Adolesc Psychiatry       Date:  1996-11       Impact factor: 8.829

2.  An open-label trial of tomoxetine in pediatric attention deficit hyperactivity disorder.

Authors:  C J Kratochvil; D Bohac; M Harrington; N Baker; D May; W J Burke
Journal:  J Child Adolesc Psychopharmacol       Date:  2001       Impact factor: 2.576

Review 3.  The use of tricyclic antidepressants in children and adolescents.

Authors:  J M Daly; T Wilens
Journal:  Pediatr Clin North Am       Date:  1998-10       Impact factor: 3.278

4.  An open trial of venlafaxine in the treatment of attention-deficit/hyperactivity disorder in children and adolescents.

Authors:  R L Olvera; S R Pliszka; J Luh; R Tatum
Journal:  J Child Adolesc Psychopharmacol       Date:  1996       Impact factor: 2.576

5.  Efficacy of modafinil compared to dextroamphetamine for the treatment of attention deficit hyperactivity disorder in adults.

Authors:  F B Taylor; J Russo
Journal:  J Child Adolesc Psychopharmacol       Date:  2000       Impact factor: 2.576

6.  Effects of modafinil in children with attention-deficit/hyperactivity disorder: an open-label study.

Authors:  T A Rugino; T C Copley
Journal:  J Am Acad Child Adolesc Psychiatry       Date:  2001-02       Impact factor: 8.829

Review 7.  Pharmacotherapy of attention-deficit hyperactivity disorder across the life cycle.

Authors:  T Spencer; J Biederman; T Wilens; M Harding; D O'Donnell; S Griffin
Journal:  J Am Acad Child Adolesc Psychiatry       Date:  1996-04       Impact factor: 8.829

8.  Atomoxetine and methylphenidate treatment in children with ADHD: a prospective, randomized, open-label trial.

Authors:  Christopher J Kratochvil; John H Heiligenstein; Ralf Dittmann; Thomas J Spencer; Joseph Biederman; Joachim Wernicke; Jeffrey H Newcorn; Charles Casat; Denai Milton; David Michelson
Journal:  J Am Acad Child Adolesc Psychiatry       Date:  2002-07       Impact factor: 8.829

9.  The 4-year course of tic disorders in boys with attention-deficit/hyperactivity disorder.

Authors:  T Spencer; M Biederman; B Coffey; D Geller; T Wilens; S Faraone
Journal:  Arch Gen Psychiatry       Date:  1999-09

10.  Six-week, double-blind, placebo-controlled study of desipramine for adult attention deficit hyperactivity disorder.

Authors:  T E Wilens; J Biederman; J Prince; T J Spencer; S V Faraone; R Warburton; D Schleifer; M Harding; C Linehan; D Geller
Journal:  Am J Psychiatry       Date:  1996-09       Impact factor: 18.112
View more
  2 in total

1.  Viloxazine for Attention-Deficit Hyperactivity Disorder: A Systematic Review and Meta-analysis of Randomized Clinical Trials.

Authors:  Alok Singh; Mahesh Kumar Balasundaram; Abhishek Singh
Journal:  J Cent Nerv Syst Dis       Date:  2022-05-20

Review 2.  Methylphenidate extended-release oral suspension for the treatment of attention-deficit/hyperactivity disorder: a practical guide for pharmacists.

Authors:  Joshua Caballero; Edress H Darsey; Faith Walters; Heidi W Belden
Journal:  Integr Pharm Res Pract       Date:  2017-10-17
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.